FDA pulls preterm-birth drug Makena and its generics from market after 12 years By: MarketWatch April 06, 2023 at 13:57 PM EDT The drug, which was approved using an accelerated pathway in 2011, showed no clinical benefit in a later trial. Read More >> Related Stocks: Apollo Global Management, Inc. (New) Common Stock
